STOCK TITAN

Corvex (MOVE) director granted 100,000 RSUs and 200,000 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Corvex, Inc. director Patrick Fleury reported equity awards that increase his stake in the company. He received 100,000 shares of common stock as a grant, structured as time-based restricted stock units that vest in three equal annual installments from the grant date.

He was also granted stock options for 200,000 shares of common stock at an exercise price of $21.06 per share, expiring on July 1, 2036. These options vest in three equal annual installments from the grant date. After these awards, his reported direct holdings are 100,000 shares and options on 200,000 shares.

Positive

  • None.

Negative

  • None.
Insider Fleury Patrick
Role null
Type Security Shares Price Value
Grant/Award Stock Options (Right to Buy) 200,000 $0.00 --
Grant/Award Common stock 100,000 $0.00 --
Holdings After Transaction: Stock Options (Right to Buy) — 200,000 shares (Direct, null); Common stock — 100,000 shares (Direct, null)
Footnotes (1)
  1. Represents a grant of time-based restricted stock units that vest in three equal annual installments from the grant date. Options will vest in three equal annual installments from the grant date.
Restricted stock units granted 100,000 shares Time-based RSUs vesting in three equal annual installments from grant date
Stock options granted 200,000 options Options on common stock vesting in three equal annual installments
Option exercise price $21.06 per share Strike price for 200,000 stock options
Option expiration date July 1, 2036 Expiration for granted stock options
Shares held after grant 100,000 shares Total direct common shares following the restricted stock unit grant
Options held after grant 200,000 options Total stock options following the award
restricted stock units financial
"Represents a grant of time-based restricted stock units that vest in three equal annual installments"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Options (Right to Buy) financial
"Stock Options (Right to Buy) with an exercise price of 21.0600 and expiration date July 1, 2036"
time-based financial
"Represents a grant of time-based restricted stock units that vest in three equal annual installments"
vest financial
"Options will vest in three equal annual installments from the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fleury Patrick

(Last)(First)(Middle)
C/O CORVEX, INC.
3401 NORTH FAIRFAX DRIVE, SUITE 3230

(Street)
ARLINGTON VIRGINIA 22226

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Corvex, Inc. [ MOVE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock07/01/2026A100,000(1)A$0100,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy)$21.0607/01/2026A200,000 (2)07/01/2036Common Stock200,000$0200,000D
Explanation of Responses:
1. Represents a grant of time-based restricted stock units that vest in three equal annual installments from the grant date.
2. Options will vest in three equal annual installments from the grant date.
/s/ Patrick Fleury, by Mark R. Busch, attorney-in-fact07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Corvex (MOVE) director Patrick Fleury report?

Patrick Fleury reported receiving equity awards, not open-market trades. He was granted 100,000 restricted stock units and stock options for 200,000 shares, both vesting over three years, as part of his compensation package with Corvex, Inc.

How many Corvex (MOVE) shares did Patrick Fleury acquire in this Form 4?

The filing shows a grant of 100,000 shares of common stock in the form of time-based restricted stock units. These units vest in three equal annual installments from the grant date, so the full amount becomes available gradually rather than immediately.

What stock options were granted to Patrick Fleury by Corvex (MOVE)?

He received stock options covering 200,000 shares of Corvex common stock. The options have an exercise price of $21.06 per share, expire on July 1, 2036, and vest in three equal annual installments from the grant date, aligning with long-term incentives.

Is Patrick Fleury’s Corvex (MOVE) Form 4 a stock purchase or sale?

The Form 4 reports grant or award acquisitions, not market purchases or sales. Both transactions use code “A,” indicating equity compensation: restricted stock units and stock options granted by the company, rather than shares bought or sold on the open market.

How much Corvex (MOVE) stock does Patrick Fleury hold after these awards?

After the reported transactions, his direct holdings are 100,000 shares of common stock and stock options for 200,000 underlying shares. The restricted units and options vest over three years, so access to the full position increases gradually as vesting milestones are met.